Most just lately, it's been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical spots as classical opioid receptors, it binds to some wide array of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger https://mohamedq333fdz1.topbloghub.com/profile